Search Within

DRUG-INDUCED OBESITY
Drug Targets for Obesity and Depression: From Serotonin to Leptin

Journal: Current Drug Targets
Volume: 17,Issue: 11
Page: 1282-1291
Authors: Darakhshan Jabeen Haleem

Hypoglycemic and Hypolipidemic Effects of Aqueous Extracts of Ajuga iva and Centaurium erythreae on a Rodent Model of Metabolic Syndrome

Journal: The Natural Products Journal
Volume: 7,Issue: 1
Page: 47-57
Authors: Adel Tahraoui, Zafar H. Israili and Badiaa Lyoussi

The Effects of Obesity on Drug Metabolism in Children

Journal: Drug Metabolism Letters
Volume: 9,Issue: 2
Page: 88-98
Authors: Steffen G. Oeser, Luc R.A. Rougee and Abby C. Collier

Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 7
Page: 895-903
Authors: Maksim L. Maksimov, Andrey A. Svistunov, Vadim V. Tarasov, Vladimir N. Chubarev, Marco Ávila-Rodriguez, George E. Barreto, Olga V. Dralova and Gjumrakch Aliev

Obesity: The Metabolic Disease, Advances on Drug Discovery and Natural Product Research

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 23
Page: 2577-2604
Authors: Mafalda Castro, Marco Preto, Vitor Vasconcelos and Ralph Urbatzka

Classification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and Obesity

Journal: Current Diabetes Reviews
Volume: 12,Issue: 4
Page: 414-428
Authors: Jogeshwar Mukherjee, Aparna Baranwal and Kimberly N. Schade

Evolving Larger: Dosing Anti-Tuberculosis (TB) Drugs in an Obese World

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 32
Page: 4748-4751
Authors: Ronald G. Hall II

Melissa of cinalis and Vitamin E as the Potential Therapeutic Candidates for Reproductive Toxicity Caused by Anti-cancer Drug, Cisplatin, in Male Rats

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 12,Issue: 1
Page: 73-80
Authors: Maryam Iman, Mostafa Araghi, Toktam Heidari and Vahid Mohammadi

GPR 120: The Potential Target for Obesity Treatment

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 16,Issue: 1
Page: 8-11
Authors: Peter A. Tanagho and Kyrillus S. Shohdy

Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern

Journal: Current Drug Safety
Volume: 11,Issue: 3
Page: 267-269
Authors: Upinder Kaur, Sankha Shubhra Chakrabarti and Indrajeet Singh Gambhir

Male fertility and obesity: are ghrelin, leptin and glucagon-like peptide-1 pharmacologically relevant?

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 7
Page: 783-791
Authors: Marco G. Alves, Tito T. Jesus, Mário Sousa, Erwin Goldberg, Branca M. Silva and Pedro F. Oliveira

The Current Role of Liraglutide in the Pharmacotherapy of Obesity

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 2
Page: 201-207
Authors: Georgios A. Christou, Niki Katsiki and Dimitrios N. Kiortsis

Multiple Drugs Causing Severe Anemia in Infective Endocarditis

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 16,Issue: 1
Page: 3-5
Authors: Ajit Singh, Prasad N. Shetty, Brij Mohan Kumar Singh and Tom Devasia

Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias

Journal: Current Cardiology Reviews
Volume: 12,Issue: 2
Page: 141-154
Authors: Luigi X. Cubeddu

Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) – Lesson from Adjudin

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 7
Page: 701-713
Authors: Haiqi Chen, Dolores D. Mruk, Weiliang Xia, Michele Bonanomi, Bruno Silvestrini and Chuen-Yan Cheng

Previous     Next

Go To   Results 1 - 15 of 4944